GLP-1 and Exendin-4 Transiently Enhance GABAA Receptor–Mediated Synaptic and Tonic Currents in Rat Hippocampal CA3 Pyramidal Neurons
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1) is a hormone that stimulates insulin secretion. Receptors for GLP-1 are also found in the brain, including the hippocampus, the center for memory and learning. Diabetes is a risk factor for decreased memory functions. We studied effects of GLP-1 and exendin-4, a GLP-1 receptor agonist, on γ-aminobutyric acid (GABA) signaling in hippocampal CA3 pyramidal neurons. GABA is the main inhibitory neurotransmitter and decreases neuronal excitability. GLP-1 (0.01–1 nmol/L) transiently enhanced synaptic and tonic currents, and the effects were blocked by exendin (9-39). Ten pmol/L GLP-1 increased both the spontaneous inhibitory postsynaptic current (sIPSC) amplitudes and frequency by a factor of 1.8. In 0.1, 1 nmol/L GLP-1 or 10, 50, or 100 nmol/L exendin-4, only the sIPSC frequency increased. The tonic current was enhanced by 0.01–1 nmol/L GLP-1 and by 0.5–100 nmol/L exendin-4. When action potentials were inhibited by tetrodotoxin (TTX), inhibitory postsynaptic currents decreased and currents were no longer potentiated by GLP-1 or exendin-4. In contrast, although the tonic current decreased in TTX, it was still enhanced by GLP-1 or exendin-4. The results demonstrate GLP-1 receptor regulation of hippocampal function and are consistent with GLP-1 receptor agonists enhancing GABAA signaling by pre- and postsynaptic mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although GLP-1R stimulation has been shown to modulate GABAergic signaling in the hippocampus and NTS (38–40), the effects of GLP-1R agonism on GABAergic synapses in the CeA and ILC, especially in the context of alcohol drinking, are unknown.”
From The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission (2023) · cites this paper as [38]
Citations
Cites
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · cited 7×
“Initially, the peptide GLP-1 (1-37) was identified from this processing, but later it was shown that there were two shorter peptides, GLP-1 (7-37) and GLP-1 (7-36)amide, that were the active species in vivo.”
BackgroundMethodInfluentialThe three-dimensional organization of the hippocampal formation: A review of anatomical data
Amaral, D. G., & Witter, M. P. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90424-7 · Cited by 2,180 · cited 1×
“Both the CA3 and the CA1 neurons have critical roles in hippocampal-dependent memory and learning processes (43).”
BackgroundVariations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081 · cited 7×
“Exendin (9-39) (Ex9-39) is a competitive inhibitor of GLP-1 at the GLP-1 receptor (23).”
BackgroundMethodResultInfluentialPharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500 · cited 7×
“Exendin (9-39) (Ex9-39) is a competitive inhibitor of GLP-1 at the GLP-1 receptor (23).”
BackgroundMethodInfluentialThe role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals
Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.455 · Cited by 1,122
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851 · cited 7×
“Exendin (9-39) (Ex9-39) is a competitive inhibitor of GLP-1 at the GLP-1 receptor (23).”
BackgroundMethodInfluentialTonically active GABAA receptors: modulating gain and maintaining the tone
Semyanov, A., Walker, M. C., Kullmann, D. M., & Silver, R. A. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.03.005 · Cited by 743 · cited 8×
“Exendin (9-39) (Ex9-39) is a competitive inhibitor of GLP-1 at the GLP-1 receptor (23).”
BackgroundMethodResultInfluentialMojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724
Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 551 · cited 1×
“Initially, the peptide GLP-1 (1-37) was identified from this processing, but later it was shown that there were two shorter peptides, GLP-1 (7-37) and GLP-1 (7-36)amide, that were the active species in vivo.”
BackgroundRecruitment of functional GABAA receptors to postsynaptic domains by insulin
Wan, Q., Xiong, Z. G., Man, H. Y., Ackerley, C. A., Braunton, J., Lu, W. Y., Becker, L. E., MacDonald, J. F., & Wang, Y. T. (1997) · Nature · doi:10.1038/41792 · Cited by 537 · cited 8×
“Exendin (9-39) (Ex9-39) is a competitive inhibitor of GLP-1 at the GLP-1 receptor (23).”
BackgroundMethodResultInfluential
Cited by
Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621
“GABA receptors to postsynaptic membranes [29,30].”
Chuong, V., Farokhnia, M., Khom, S., Pince, C. L., Elvig, S. K., Vlkolinsky, R., Marchette, R. C. N., Koob, G. F., Roberto, M., Vendruscolo, L. F., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.170671 · Cited by 214
“170671 field, showing increased GABAergic signaling in the hypothalamus (103) and hippocampus (38, 104, 105) of alcohol-naive rodents after treatment with GLP-1 or other GLP-1 analogues, which might be linked to increased intracellular cAMP levels after GLP-1R activation (39, 106, 107).”
Liu, J., Conde, K., Zhang, P., Lilascharoen, V., Xu, Z., Lim, B. K., Seeley, R. J., Zhu, J. J., Scott, M. M., & Pang, Z. P. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.042 · Cited by 190
“…profound effects on synaptic transmission (for review see: Liu and Pang, 2016), however, the intracellular signaling cascades and pre- or postsynaptic site of action appear to be dependent on brain region and cell type (Acuna-Goycolea and van den Pol, 2004; Korol et al., 2015; Wang et al., 2015).”
Hamzé, R., Delangre, E., Tolu, S., Moreau, M., Janel, N., Bailbé, D., & Movassat, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315287 · Cited by 158
“Furthermore, insulin is implicated in the recruitment of the GABA (gamma-aminobutyric acid) receptor to the postsynaptic membrane, thus regulating inhibitory synapses [28,59,70,80,81].”
BackgroundGault, V. A., Lennox, R., & Flatt, P. R. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12432 · Cited by 141
“The precise mechanisms underlying the positive actions of GLP-1 receptor agonists on cognition are not yet known, but evidence points towards improved hippocampal synaptic plasticity and reduced GABAA receptor-mediated synaptic and tonic currents in CA3 pyramidal neurons [41,53].”
GLP-1’s role in neuroprotection: a systematic review
Erbil, D., Eren, C. Y., Demirel, C., Küçüker, M. U., Solaroğlu, I., & Eser, H. Y. (2019) · Brain Injury · doi:10.1080/02699052.2019.1587000 · Cited by 126
Fortin, S. M., Lipsky, R. K., Lhamo, R., Chen, J., Kim, E., Borner, T., Schmidt, H. D., & Hayes, M. R. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8071 · Cited by 127
“food intake: Glucagon-like peptide 1-(7-36) amide acts at lateral and medial”
BackgroundHernandez, N. S., Ige, K. Y., Mietlicki-Baase, E. G., Molina-Castro, G. C., Turner, C. A., Hayes, M. R., & Schmidt, H. D. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0010-3 · Cited by 123
Kim, Y.-K., Kim, O. Y., & Song, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01270 · Cited by 109
“It was previously shown that the GLP-1 receptor can control neuronal function in the rat hippocampus by enhancing GABAA signaling through presynaptic and postsynaptic mechanisms (Korol et al., 2015).”
BackgroundPPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation
Trapp, S., & Cork, S. C. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00333.2015 · Cited by 100
Maimaiti, S., Anderson, K. L., DeMoll, C., Brewer, L. D., Rauh, B. A., Gant, J. C., Blalock, E. M., Porter, N. M., & Thibault, O. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu314 · Cited by 87
Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
Diz-Chaves, Y., Herrera-Pérez, S., González-Matías, L. C., Lamas, J. A., & Mallo, F. (2020) · Nutrients · doi:10.3390/nu12113304 · Cited by 84
Modulation of Hippocampal Neural Plasticity by Glucose-Related Signaling
Mainardi, M., Fusco, S., & Grassi, C. (2015) · Neural Plasticity · doi:10.1155/2015/657928 · Cited by 81
“Finally, GLP-1 appears to affect mainly basal inhibitory synaptic transmission, as it has been shown to increase both frequency and amplitude of GABAergic spontaneous inhibitory postsynaptic currents (sIPSCs) recorded from CA3 neurons [98].”
BackgroundGLP-1 receptor agonists show neuroprotective effects in animal models of diabetes
Gault, V. A., & Hölscher, C. (2018) · Peptides · doi:10.1016/j.peptides.2017.11.017 · Cited by 86
Detka, J., & Głombik, K. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00274-8 · Cited by 79
Farkas, I., Vastagh, C., Farkas, E., Bálint, F., Skrapits, K., Hrabovszky, E., Fekete, C., & Liposits, Z. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00214 · Cited by 79
“Furthermore, GLP-1 is able to modulate GABAA-Rmediated synaptic currents in hippocampus (Korol et al., 2015) providing further confirmation of our results.”
ResultHernandez, N. S., O'Donovan, B., Ortinski, P. I., & Schmidt, H. D. (2019) · Addiction Biology · doi:10.1111/adb.12583 · Cited by 79
Cerebral cortex: a target and source of insulin?
Csajbók, É., & Tamás, G. (2016) · Diabetologia · doi:10.1007/s00125-016-3996-2 · Cited by 90
Functional Characterization of Native, High-Affinity GABAA Receptors in Human Pancreatic β Cells
Korol, S. V., Jin, Z., Jin, Y., Bhandage, A. K., Tengholm, A., Gandasi, N. R., Barg, S., Espes, D., Carlsson, P., Laver, D. R., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.03.014 · Cited by 78
Self-citationLourenco, M. V., Ferreira, S. T., & Felice, F. G. D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.03.003 · Cited by 83
Nader, M. A., Ateyya, H., El‐Shafey, M., & El-Sherbeeny, N. A. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.10.006 · Cited by 75
“In a recent study GLP-1 agonist and exendin-4, a GLP-1mimetic, were found to increase GABA signaling in rat hippocampal CA3 pyramidal neurons (Korol et al., 2015).”
Merkel, R., Hernandez, N. S., Weir, V. R., Zhang, Y., Caffrey, A., Rich, M. T., Crist, R. C., Reiner, B. C., & Schmidt, H. D. (2025) · Science Advances · doi:10.1126/sciadv.adr5051 · Cited by 79
Central GLP-1 receptors: Novel molecular targets for cocaine use disorder
Hernandez, N. S., & Schmidt, H. D. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.03.026 · Cited by 63
“GLP-1 signaling has also been shown to regulate other neurotransmitter systems including glutamatergic [134] and GABAergic [155, 166] transmission in the brain.”
BackgroundInfluentialColvin, K. J., Killen, H. S., Kanter, M. J., Halperin, M. C., Engel, L., & Currie, P. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249710 · Cited by 61
“Evidence suggests that GLP-1 and GABAergic systems interact in the CA3 region of the hippocampus [66], although additional research is needed to explore this relationship within the LH.”
BackgroundPotential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes
Palleria, C., Leporini, C., Maida, F., Succurro, E., Sarro, G. D., Arturi, F., & Russo, E. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.07.002 · Cited by 65
Koshal, P., & Kumar, P. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2678-1 · Cited by 58
Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1
Jerlhag, E. (2020) · Brain Research · doi:10.1016/j.brainres.2019.146562 · Cited by 53
“This is further evident as Ex4 and liralglutide have different efficacy when it comes to release GABA in hippocampus (Babateen et al., 2017; Korol et al., 2015a; Korol et al., 2015b).”
BackgroundTherapeutic application of GLP-1 and GIP receptor agonists in Parkinson’s disease
Yang, X., Feng, P., Ji, R., Ren, Y., Wei, W., & Hölscher, C. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2079492 · Cited by 50
Liu, W., Son, D. O., Lau, H., Zhou, Y., Prud’homme, G. J., Jin, T., & Wang, Q. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00362 · Cited by 53
“In rat hippocampal CA3 pyramidal neurons, both native GLP-1 and its agonist exendin-4 were shown to enhance GABAA receptor-mediated synaptic and tonic currents (Korol et al., 2015).”
BackgroundMansur, R. B., Lee, Y., Subramaniapillai, M., Brietzke, E., & McIntyre, R. S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.048 · Cited by 47
“For example, it is reported that GLP-1 signaling regulates neurotransmitters release (e.g. glutamate, gammaaminobutyric acid [GABA] and dopamine) in hippocampal and striatal neurons (Oka et al., 1999; Korol et al., 2015; Reddy et al., 2016; Fortin and Roitman, 2017).”
BackgroundAl-Kuraishy, H. M., Hussian, N., Al-Naimi, M. S., Al-Gareeb, A. I., Al-Mamorri, F., & Al-Buhadily, A. K. C. (2021) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_278_19 · Cited by 53
Rebosio, C., Balbi, M., Passalacqua, M., Ricciarelli, R., & Fedele, E. (2018) · BioFactors · doi:10.1002/biof.1406 · Cited by 46
Glucagon-like Peptide-1 (GLP-1) and neurotransmitters signaling in epilepsy: An insight review
Koshal, P., Jamwal, S., & Kumar, P. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.015 · Cited by 44
“In the samemanner, treatment of GLP-1 and GLP-1 analog Exendine-4 have been reported to increase synaptic and tonic GABAergic current in rat hippocampal pyramidal neurons (Korol et al., 2015a,b).”
Manavi, M. A. (2022) · Neuropeptides · doi:10.1016/j.npep.2022.102250 · Cited by 40
Flood, L., Korol, S. V., Ekselius, L., Birnir, B., & Jin, Z. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577050 · Cited by 45
“Whole-cell voltage-clamp recordings were performed at room temperature as previously described (Jin et al., 2011b; Korol et al., 2015).”
MethodSelf-citationGullo, F., Ceriani, M., D'Aloia, A., Wanke, E., Constanti, A., Costa, B., & Lecchi, M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00500 · Cited by 35
“There is evidence that the gut hormone GLP-1 is also produced in the brain (Korol et al., 2015; Thiebaud et al., 2016).”
BackgroundAllingbjerg, M.-L., Hansen, S. N., Secher, A., & Thomsen, M. (2022) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000620 · Cited by 37
Tufvesson‐Alm, M., Shevchouk, O. T., & Jerlhag, E. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1092828 · Cited by 38
Zhang, Y., Liu, Y.-L., Xu, J., Sun, Q., Yu, F., Cheng, J., Peng, B., Liu, W., Xiao, Z., Yin, J., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.004 · Cited by 36
Piątkowska‐Chmiel, I., Gawrońska‐Grzywacz, M., Popiołek, Ł. P., Herbet, M., & Dudka, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-10187-y · Cited by 36
Lietzau, G., Nyström, T., Östenson, C., Darsalia, V., & Patrone, C. (2016) · Oncotarget · doi:10.18632/oncotarget.6823 · Cited by 33
Liu, S., Jin, Z., Zhang, Y., Rong, S., He, W., Sun, K., Wan, D., Huo, J., Xiao, L., Li, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00136 · Cited by 36
“, 2015), suggesting the GLP-1 signaling could modulate a variety of neuronal functions (Korol et al., 2015; Prashant et al., 2018).”
BackgroundSelf-citationHammoud, H., Netsyk, O., Tafreshiha, A. S., Korol, S. V., Jin, Z., Li, J.-P., & Birnir, B. (2021) · Acta Physiologica · doi:10.1111/apha.13623 · Cited by 31
Self-citationInhibitory effects of glucagon-like peptide-1 receptor on epilepsy
Wen, Y., Wu, K., Xie, Y., Dān, W., Zhan, Y., & Shi, Q. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.028 · Cited by 33
Edvardsson, C. E., Cadeddu, D., Ericson, M., Adermark, L., & Jerlhag, E. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105684 · Cited by 33
“…other brain regions, where some of the effects of GLP-1R agonists are mediated by GABA transmission, 29,37,64,72,101 – 104 speci fi cally GABA A R. 72,101,103 – 105 Given that the LS is primarily composed of GABAergic neurons 48 – 50 which highly express GLP-1R, 18,19,21 and that inhibition of…”
Son, D. O., Liu, W., Li, X., Prud’homme, G. J., & Wang, Q. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12881 · Cited by 31
Solmaz, V., Tekataş, A., Erdoğan, M. A., & Erbaş, O. (2020) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10056 · Cited by 29
Koshal, P., & Kumar, P. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1890-4 · Cited by 33
Glucagon‐like peptide‐1 drives energy metabolism on the synaptic highway
Liu, J., & Pang, Z. P. (2016) · The FEBS Journal · doi:10.1111/febs.13785 · Cited by 28
Peptides and aging: Their role in anorexia and memory
Morley, J. E. (2015) · Peptides · doi:10.1016/j.peptides.2015.04.007 · Cited by 29
Larsson, M., Lietzau, G., Nathanson, D., Östenson, C., Mallard, C. E., Johansson, M. E., Nyström, T., Patrone, C., & Darsalia, V. (2016) · Bioscience Reports · doi:10.1042/bsr20160437 · Cited by 29
Zhu, C., Li, H., Kong, X., Wang, Y., Sun, T., & Wang, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.819470 · Cited by 26
Korol, S. V., Jin, Z., & Birnir, B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124765 · Cited by 26
Self-citationGABA signalling in human pancreatic islets
Jin, Z., & Korol, S. V. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1059110 · Cited by 30
“We have previously shown in hippocampal CA3 pyramidal neurons that one of the mechanisms of action of GLP-1, and its analogue exendin-4, is a stimulation of GABA release from presynaptic vesicles (25, 26).”
BackgroundSelf-citationFlintoff, J. M., Kesby, J. P., Siskind, D. J., & Burne, T. H. J. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1951702 · Cited by 25
The role of the lateral septum in neuropsychiatric disease
Patel, H. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25052 · Cited by 29
Pharmacology of GABA and Its Receptors
Kaur, S., Singh, S., Arora, A., Ram, P., Kumar, S., Kumar, P., & Abed, S. N. (2020) · Springer eBooks · doi:10.1007/978-981-15-3556-7_8 · Cited by 25
Augestad, I. L., Dekens, D., Karampatsi, D., Elabi, O., Zabala, A., Pintana, H., Larsson, M., Nyström, T., Paul, G., Darsalia, V., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15524 · Cited by 21
“…role in facilitating functional recovery after stroke (Johnstone et al., 2018) and recently it has been shown that GLP-1 receptor activation can modulate GABA signalling (Korol et al., 2015) and affects specific populations of GABAergic interneurons (Larsson et al., 2016; Lietzau et al., 2016).”
BackgroundInsulin enhances GABAA receptor-mediated inhibitory currents in rat central amygdala neurons
Korol, S. V., Tafreshiha, A. S., Bhandage, A. K., Birnir, B., & Jin, Z. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.02.022 · Cited by 25
“Whole-cell voltage-clamp recordings were performed at room temperature as previously described [24,30].”
Self-citationErdoğan, M. A., Erdoğan, A., & Erbaş, O. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03736-4 · Cited by 28
“GLP-1 and exendin-4 have been also found to promote GABAergic signaling in both presynaptic and postsynaptic CA3 cells of the hippocampus [55].”
BackgroundBreit, S., & Hubl, D. (2025) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2025.107415 · Cited by 29
Listos, J., Listos, P., Baranowska-Bosiacka, I., Karpiuk, A., Filarowska, J., Łupina, M., Słowik, T., Zawiślak, S., & Kotlińska, J. (2022) · Molecules · doi:10.3390/molecules27082478 · Cited by 20
“This effect was also demonstrated in the hippocampal CA3 pyramidal neurons of rats wherein stimulation of the GLP-1 receptors increased GABA release from the presynaptic membrane and intensified GABAergic signalization [66].”
BackgroundExpression of GLP-1 receptors in insulin-containing interneurons of rat cerebral cortex
Csajbók, É., Kocsis, Á. K., Faragó, N., Furdan, S., Kovács, B., Lovas, S., Molnár, G., Likó, I., Zvara, Á., Puskás, L. G., et al. (2019) · Diabetologia · doi:10.1007/s00125-018-4803-z · Cited by 20
Babateen, O., Korol, S. V., Jin, Z., Bhandage, A. K., Ahemaiti, A., & Birnir, B. (2017) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-017-0191-0 · Cited by 19
Self-citationObesity and Depression: Common Link and Possible Targets
Jitte, S., Keluth, S., Bisht, P., Wal, P., Singh, S., Murti, K., & Kumar, N. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273291985240430074053 · Cited by 15
Shao, Y., Wang, Y., Wang, L., Ruan, H.-Z., Liu, Y., Zhang, T. J., Weng, S.-J., Yang, X.-L., & Zhong, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00001 · Cited by 17
Yu, Z.-W., Liu, R., Li, X., Wang, Y., Fu, Y., Li, H.-Y., Yuan, Y., & Gao, X. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111294 · Cited by 15
Vastagh, C., Farkas, I., Scott, M. M., & Liposits, Z. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02167-7 · Cited by 17
Llach, C.-D., Badulescu, S., Tabassum, A., Shah, H., Gill, H., Le, G. H., Vieta, E., McIntyre, R. S., Rosenblat, J. D., & Mansur, R. B. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03261-0 · Cited by 20
“Additionally, exendin-4 transiently increases tonic and synaptic currents mediated by GABA receptors in the hippocampus [41, 42] and laterodorsal tegmental nucleus [43], mitigating neuronal hyperexcitability and potentially stabilizing cognitive and emotional fl uctuations associated with BD. GLP-1…”
The role of the GLP-1/GLP-1R signaling pathway in regulating seizure susceptibility in rats
Zhang, Y., Fang, J., Feng, W., Sun, Q., Xu, J., & Xia, Q. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.017 · Cited by 14
Ceceli, A. O., Huang, Y., Kronberg, G., McClain, N. E., King, S. G., Butelman, E. R., Alia‐Klein, N., & Goldstein, R. Z. (2025) · Annual Review of Psychology · doi:10.1146/annurev-psych-040725-025923 · Cited by 23
“Glucagon-like peptide-1 agonists also modulate GABAA receptors (Korol et al. 2015), through which they reduce alcohol intake in rodents (Chuong et al. 2023).”
Ghrelin system and GLP-1 as potential treatment targets for alcohol use disorder
Jerlhag, E. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.07.006 · Cited by 13
Zhang, T., Ruan, H.-Z., Wang, Y., Shao, Y., Zhou, W., Weng, S.-J., & Zhong, Y. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00826-9 · Cited by 11
“Different from our results, GLP-1/exendin-4 increases GABAAR-mediated tonic currents and GABAAR-mediated spontaneous IPSC frequency through GLP-1R activation in rat hippocampal CA3 pyramidal neurons [14].”
BackgroundResultFarokhnia, M., Sheskier, M. B., Lee, M. R., Le, A. N., Singley, E., Bouhlal, S., Ton, T., Zhao, Z., & Leggio, L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.011 · Cited by 13
“hand, GLP-1 receptor activation enhances GABA formation and neurotransmission (Korol et al., 2015;Wang et al., 2007) and, on the”
Sarro, C. D., Tallarico, M., Pisano, M., Gallelli, L., Citraro, R., Sarro, G. D., & Leo, A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175098 · Cited by 10
Wang, X.-Y., Liu, Y., Cao, L.-X., Li, Y.-Z., Wan, P., & Qiu, D. (2023) · Scientific Reports · doi:10.1038/s41598-023-34070-6 · Cited by 12
GLP‐1 at the Metabolic–Cognitive Interface: Reward, Affect, and Memory
Gao, S., Décarie-Spain, L., Gu, C., Mazzini, G., Kanoski, S. E., & Borner, T. (2026) · Comprehensive physiology · doi:10.1002/cph4.70129 · Cited by 14
“…evidence linking GLP-1R signaling to long-term depression (LTD) is limited; to our knowledge, no studies have directly demonstrated GLP- 1-dependent LTD induction, though indirect modulation of inhibitory tone and synaptic homeostasis has been reported in hippocampal CA3 slices (Korol et al. 2015).”
Zhou, Y., Dong, J., Song, J., Lvy, C., & Zhang, Y. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220751 · Cited by 11
Caffrey, A., Lavecchia, E., Chichura, K. S., Hayes, M. R., Doyle, R. P., & Schmidt, H. D. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70096 · Cited by 7
“Electro-physiology studies showing that Ex-4 potentiates GABA-mediated postsynaptic inhibitory currents in the brain further support this hypothesis (Korol et al., 2015).”
Synthetic exendin-4 disrupts responding to reward predictive incentive cues in male rats
Wakabayashi, K. T., Baindur, A. N., Feja, M., Suarez, M., Chen, K., Bernosky‐Smith, K. A., & Bass, C. E. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1363497 · Cited by 5
Edvardsson, C. E., Zhang, X., Emous, T. A., Adermark, L., Witley, S., Ericson, M., Schmidt, H. D., & Jerlhag, E. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106219 · Cited by 7
“2,63 GLP-1R agonists have also been shown to influence inhibitory GABA tone and excitatory glutamate signalling within several brain circuits, 20,24,25,35,69–75 including studies with the cocaine, 20,24,25 potentially explaining the neurochemical data.”
Shen, J., Wang, M., Pang, G., Zhang, Y., Zhang, J., Shi, Y., Liu, J., & Zhan, C. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00528.2024 · Cited by 7
Activation of glucagon‐like peptide‐1 receptors and skilled reach foraging
Vestlund, J., Bergquist, F., Licheri, V., Adermark, L., & Jerlhag, E. (2020) · Addiction Biology · doi:10.1111/adb.12953 · Cited by 8
Exendin-4 increases the firing activity of hippocampal CA1 neurons through TRPC4/5 channels
Sun, H.-Z., Shen, F.-S., Li, X.-X., Liu, C., Xue, Y., Han, X., Chen, X., & Chen, L. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.08.001 · Cited by 4
“In hippocampal CA3 pyramidal neurons, GLP-1 and exendin-4 enhance GABA A receptor-mediated spontaneous inhibitory postsynaptic currents in an exendin(9 (cid:0) 39)-and TTX-sensitive way (Korol et al., 2015).”
BackgroundPunapart, M., Reimets, R., Seppa, K., Kirillov, S., Gaur, N., Eskla, K., Jagomäe, T., Vasar, E., & Plaas, M. (2023) · Genes · doi:10.3390/genes14040827 · Cited by 4
“Moreover, GLP-1R agonists have been shown to abate microglial activation in vivo in WS rats [25] and increase GABAergic neurotransmission in different disease conditions, including ischemia [78,79].”
BackgroundDing, H., Wang, M., Zhang, J., Wan, C., Huang, Z., Liu, L., & Liu, J. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00174.2025 · Cited by 5
Herman, R. J., Caffrey, A., Pothikamjorn, A., Zhang, X., Fortuna, R. P., & Schmidt, H. D. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.05.002 · Cited by 2
Impact of Semaglutide on Hippocampal Injury in a Streptozotocin-Induced Model of Alzheimer’s Disease
Stavrovskaya, A. V., Pavlova, A. K., Воронков, Д. Н., Olshansky, A. S., Romanenko, A. S., Fedorova, E. N., Simonenko, A. V., Sukhorukov, V. S., & Illarioshkin, S. N. (2026) · Biomedicines · doi:10.3390/biomedicines14061257 · Cited by 1
“Pharmacological activation of GLP1R has been shown to affect GABAergic tonic currents in cortical [18], hypothalamic [19], and hippocampal neurons [20].”
Fu, X., Xie, Y., Xie, Y., Han, A., Zhou, X., Zhang, S., Shen, C., Zhang, Y., Wang, L., & Xie, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1860661 · Cited by 1
“For example, studies have reported that liraglutide, a GLP-1 analogue, upregulates the level of glutamic acid decarboxylase 67 (GAD-67) in GABAergic neurons of epileptic mice (69).”
Antiepileptic effects of exenatide in penicillin induced acute epilepsy model in rats
Yildiz, A., Kocacan, S. E., & Him, A. (2023) · Indian Journal of Experimental Biology · doi:10.56042/ijeb.v61i06.1931 · Cited by 2
Netsyk, O., Korol, S. V., Westermark, G. T., Birnir, B., & Jin, Z. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1531790 · Cited by 1
Self-citationThe Connection Between the Appetite-Regulatory Peptides Ghrelin and GLP-1 and Alcohol Use Disorder
Jerlhag, E. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-89525-8_8 · Cited by 2
Augestad, I. L., Dekens, D. W., Karampatsi, D., Elabi, O. F., Zabala, A., Pintana, H., Larsson, M., Nyström, T., Paul, G., Darsalia, V., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-210113/v1 · Cited by 1
Glutamate and GABA signalling components in the human brain and in immune cells
Bhandage, A. K. (2016) · Uppsala University Publications (Uppsala University) · Cited by 3
Exendin-4 disrupts responding to reward predictive incentive cues in ratsPreprint
Wakabayashi, K. T., Baindur, A. N., Feja, M., Chen, K., Bernosky‐Smith, K. A., & Bass, C. E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/315705
Expression of insulin and GLP-1 receptors in interneurons of the cerebral cortex
Csajbók, É. (2019) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10078
“Moreover, considering the effect of GLP-1 in enhancing synaptic and tonic inhibitory currents arriving at hippocampal pyramidal cells [106], and taking into account the high expression of extrasynaptic GABA type A (GABAA) receptor delta subunits found on intermediate and distal dendrites of neurogliaform cells [73], w…”
BackgroundHolm, M. M. (2021) · Acta Physiologica · doi:10.1111/apha.13660
Neuroprotective Effect of Sitagliptin beyond the Incretin Effect: A Narrative Review
Pourbagher‐Shahri, A. M., & Forouzanfar, F. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273367858250321124131
Netsyk, O., Korol, S. V., Birnir, B., & Jin, Z. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1638550 · Cited by 4
Self-citation
Metadata
- Authors
- Korol, S. V., Jin, Z., Babateen, O., & Birnir, B.
- Affiliations
- Uppsala University (SE)
- Corresponding author
- Birnir, Bryndis
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-08-11
- Volume
- 64
- Issue
- 1
- Pages
- 79-89
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2161146234
- Cited by
- 101
- References
- 52
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 4 · 2023: 8 · 2022: 12 · 2021: 7 · 2020: 10 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 10 · 2015: 7
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- green
- urn.kb.se
- Licence
- other-oa
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucagon-like peptide-1, exendin-4, GLP-1 receptor, GABAA receptor, hippocampal CA3 pyramidal neurons, inhibitory postsynaptic currents, tonic inhibition, GABA signaling, exendin-9-39, tetrodotoxin, synaptic inhibition
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Exenatide, Animals, gamma-Aminobutyric Acid, Membrane Potentials, Memory, Synaptic Transmission, Organ Culture Techniques, Peptides, Receptors, GABA-A, Tetrodotoxin, Venoms, Signal Transduction, Rats, Wistar, Pyramidal Cells, Receptors, Glucagon, Patch-Clamp Techniques, Sodium Channel Blockers, Glucagon-Like Peptide 1, Inhibitory Postsynaptic Potentials, CA3 Region, Hippocampal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.